Stay updated on APR-246+Azacitidine Post-AlloSCT in TP53 Mut AML/MDS Clinical Trial
Sign up to get notified when there's something new on the APR-246+Azacitidine Post-AlloSCT in TP53 Mut AML/MDS Clinical Trial page.

Latest updates to the APR-246+Azacitidine Post-AlloSCT in TP53 Mut AML/MDS Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision entry (v3.4.2) was added to the history, and older notices about funding and the previous revision (v3.4.1) were removed.SummaryDifference0.7%

- Check21 days agoChange DetectedRecord History shows a new site-wide notice about government funding and an updated Revision: v3.4.1, with the previous Revision: v3.4.0 removed. These maintenance updates do not affect trial content, data, or user-facing study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check28 days agoChange DetectedUI improvements include a glossary toggle and color-coded change highlights (green for additions, red for deletions) with a legend, and explicit revision notes (e.g., v3.4.0) on the history page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1.0%

- Check42 days agoChange DetectedNew revision entry v3.3.4 was added to the study record history, and v3.3.3 was removed; this is a minor metadata update to the history log and does not alter the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedThe history shows a new site revision (v3.3.3) added and an older revision (v3.3.2) removed, along with the HHS Vulnerability Disclosure footer link. These are maintenance updates that do not change study information or how users interact with the page.SummaryDifference0.2%

- Check85 days agoChange DetectedThe page history shows a new revision entry (v3.3.2) and removal of the previous revision (v3.3.1) in the record version list. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to APR-246+Azacitidine Post-AlloSCT in TP53 Mut AML/MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APR-246+Azacitidine Post-AlloSCT in TP53 Mut AML/MDS Clinical Trial page.